孕产妇产前检测免疫学检验项目的价值分析

目的分析孕产妇产前检测免疫学检验项目的临床价值.方法选取 2015 年 1月 -2015 年12 月200 例医院接收孕产妇的临床资料进行回顾性分析,所有患者均进行免疫学检验项目（乙肝、梅毒、HIV以及病原微生物）.结果200 例孕产妇中,乙肝病毒感染孕产妇 36 例（18.0%）、梅毒感染孕产妇8 例（4.0%）、HIV感染孕产妇 5例（2.5%）、病原微生物感染2例（1.0%）.对于HIV感染或患有对胎儿影响较大且治疗难度高的疾病,首先与孕产妇及家属展开沟通,在取得其同意后终止妊娠.结论产前免疫学检测有助于尽早发现高危妊娠孕产妇,并为孕产妇及胎儿提供有效的干预措施,保障其健康安全.

Objectiveto analyze the clinical significance of detection of immunological tests of antenatal. Methodsthe clinical data of 200 cases of maternal clinical data were retrospectively analyzed from January 2015 to December in. All patients were tested for immunological tests （hepatitis B, syphilis, HIV and pathogenic microorganisms）. Results36 cases of maternal hepatitis B virus infection in 200 cases （18%）, syphilis infection in pregnant women in 8 cases （4%）, HIV infection in 5 cases （2.5%）, pathogenic microorganisms infection in 2 cases （1%）. For HIV infection or suffering from a larger impact on the fetus and treatment of disease, first of all, with maternal and family members to communicate, to obtain their consent after termination of pregnancy. Conclusionit is helpful for the early detection of high-risk pregnant women, and provide effective intervention measures to protect the health and safety of the pregnant women and the fetus.